A detailed history of Barclays PLC transactions in Beyond Air, Inc. stock. As of the latest transaction made, Barclays PLC holds 21,860 shares of XAIR stock, worth $27,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,860
Previous 37,151 41.16%
Holding current value
$27,980
Previous $73,000 47.95%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.3 - $2.15 $19,878 - $32,875
-15,291 Reduced 41.16%
21,860 $38,000
Q4 2023

Feb 15, 2024

BUY
$1.4 - $2.46 $45,316 - $79,627
32,369 Added 676.89%
37,151 $73,000
Q3 2023

Nov 07, 2023

SELL
$2.31 - $4.18 $718 - $1,299
-311 Reduced 6.11%
4,782 $11,000
Q2 2023

Aug 03, 2023

SELL
$4.26 - $6.92 $100,578 - $163,381
-23,610 Reduced 82.26%
5,093 $22,000
Q1 2023

May 04, 2023

BUY
$5.65 - $7.56 $162,171 - $216,994
28,703 New
28,703 $194,000
Q3 2022

Nov 03, 2022

BUY
$7.42 - $11.39 $10,833 - $16,629
1,460 New
1,460 $11,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $38.3M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.